Ezra Cohen, MD | Authors


The Introduction of Immunotherapy to the Treatment of Head and Neck Cancers

February 05, 2019

Ezra Cohen, MD, discusses the advancing field of immunotherapy in the treatment landscape for patients with head and neck cancers. Prior to the use of PD-1/PD-L1 blockades, which have been the most tested immunotherapy in this setting, there were little treatment options.

Dr. Ezra Cohen on Siltuximab Combinations in Head and Neck Squamous Cell Carcinoma

March 04, 2016

The two platforms involved in the study were the FHX regimen and a cisplatin radiation approach with accelerated radiation. Siltuximab was also used in the study as induction chemotherapy alongside carboplatin and paclitaxel.